Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie
about
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinomaChemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinomaEmerging treatment options for nasopharyngeal carcinomaTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaGenetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyWhat Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results.Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01).Statistical analysis of illness-death processes and semicompeting risks data.Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases.Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area.The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trialsCurrent management strategy of nasopharyngeal carcinoma.Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy?IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinomaAnalysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapyAlterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cellsTransducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-κB pathway.Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survivalRadiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in AsiaIntensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia.Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma.Analysis and design of randomised clinical trials involving competing risks endpointsThe effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapyDifferent prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrenceA Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma.
P2860
Q24200903-1843B88F-0CE7-4592-A957-DFECAAF063B3Q24243898-F7B96AA0-F549-4DD1-943B-DA26CD02EF5FQ26995560-8EE6DEE4-DA2A-46FB-9AD2-71DB870533ACQ27016002-118FFEC2-4CDF-427B-A086-9144A8478F3CQ28536735-3D8778CA-BA46-4BA2-B644-027C2971B838Q31146986-A39FDBD8-50C2-4E28-BA8A-884C4FAA3A40Q33395652-38C66AEC-FFC9-4D3F-9739-AA296C65A3BCQ33398185-1CD6DFBD-9D03-49C5-8821-95266E069D01Q33410822-4EDC031F-92A0-442F-9030-277CAA934ADFQ33428012-323C77A8-0D8A-4ECE-991F-B3F9B60DFD9AQ33429679-5FC55A28-2ACA-451A-83D7-41DB1488C8C2Q33432452-065EA807-A2E7-4739-B94A-06CD826C6790Q33435906-5110249E-D6E8-436B-801F-671E78FE860AQ33441222-E45AE97D-597F-4E49-BCE9-4DB639BCB220Q33442582-F562A125-123E-4FB7-9A5A-313D60C4F5EDQ33480709-F6AB46D0-005E-420A-9ECF-429B4E999421Q33515907-EABBEBED-FAE0-4FAD-B811-B6FDB230C11CQ33530564-2C8E65D3-B388-4781-9FCE-82F1AE16F349Q33579396-14DEFF96-142D-4F79-9A84-E2800B2D6EFDQ33632748-D11A2FE2-66A2-404D-8D85-DC3564CB43D9Q33650637-DE01E878-DE32-4800-8A20-8EAA7D1EDF24Q33719825-6A6AAC23-27E7-4603-A4A6-023ADD571947Q33764579-6ADF965C-50EF-41B0-AEEB-D6EEC414CF98Q33806554-04E98C8A-E4D0-469D-B454-4E50D9F092EAQ33889336-A9963470-6750-419C-9C59-37E4D440DA63Q33907143-E2091A99-8761-45C1-AB90-5B09D19515B0Q34001937-4934430B-2FA0-4320-AC01-2EDB65D2D39EQ34069855-22A09046-DB83-4CA0-8DF2-7D5491ED7CF3Q34105208-ABC278B4-92EE-4EE1-A246-AC9505CAE651Q34151169-F33C459A-ADCB-4A31-A58B-2DFB0A43E5DBQ34185676-0848F6EF-B64C-4CCC-AE2E-02EC25F64801Q34397133-D144E340-BE46-47E8-AA1B-F4749E251D88Q34494991-CC86CDA0-B157-4EF3-82F6-01D181F6221AQ34662664-5FEBCC1A-EDFD-4C1F-BB56-0B1D3727F038Q34722985-3DB55DE2-F42A-45DC-9A86-C3F8F9E7CAD7Q34989498-3FB4398D-ABC5-43EE-B8A2-96BB2E6ACBD0Q35089188-A5E804E2-E20B-432A-95A7-5938A76F0396Q35208691-63812E20-0A18-4C84-8958-BB25838DF407Q35326653-D20821A8-8CAE-4A83-9425-2FC3E91566DDQ35542369-341D24C5-6E6E-4DB6-8E41-746B46DF34B9
P2860
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Randomized trial of radiothera ...... al cancer of the endemic varie
@en
Randomized trial of radiothera ...... al cancer of the endemic varie
@nl
type
label
Randomized trial of radiothera ...... al cancer of the endemic varie
@en
Randomized trial of radiothera ...... al cancer of the endemic varie
@nl
prefLabel
Randomized trial of radiothera ...... al cancer of the endemic varie
@en
Randomized trial of radiothera ...... al cancer of the endemic varie
@nl
P2093
P921
P356
P1476
Randomized trial of radiothera ...... al cancer of the endemic varie
@en
P2093
Bee Choo Tai
David Machin
Edward Yang
Eng Huat Tan
Eu Jin Chua
Eu Tiong Chua
Hoon Seng Khoo Tan
Hwee Bee Wong
Joseph Wee
Kam Weng Fong
P304
P356
10.1200/JCO.2005.16.790
P407
P577
2005-09-01T00:00:00Z